Richard A. Lirio
Children's Medical Center(US)UMass Memorial Health Care(US)Takeda (United States)(US)UMass Memorial Medical Center(US)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Biosimilars and Bioanalytical Methods, Eosinophilic Esophagitis, Celiac Disease Research and Management
Most-Cited Works
- → Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis(2019)705 cited
- → Long‐term safety of vedolizumab for inflammatory bowel disease(2020)183 cited
- → Bowel Preparation for Pediatric Colonoscopy(2014)75 cited
- → Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY)(2021)46 cited
- → NASPGHAN Capsule Endoscopy Clinical Report(2016)42 cited
- → Pharmacokinetics, Safety and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn’s Disease: Results from the Phase 2 HUBBLE Study(2022)42 cited